Suchergebnisse - Caffrey, Thomas
- Treffer 1 - 20 von 27
- Zur nächsten Seite
-
1
-
2
-
3
-
4
-
5
Relevance of MUC1 mucin variable number of tandem repeats polymorphism in H pylori adhesion to gastric epithelial cells von Costa, Natália R, Mendes, Nuno, Marcos, Nuno T, Reis, Celso A, Caffrey, Thomas, Hollingsworth, Michael A, Santos-Silva, Filipe
Veröffentlicht 2008Text -
6
SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells von Wuebben, Erin L., Wilder, Phillip J., Cox, Jesse L., Grunkemeyer, James A., Caffrey, Thomas, Hollingsworth, Michael A., Rizzino, Angie
Veröffentlicht 2016Text -
7
-
8
Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells von Sousa, Andreia Mota, Rei, Margarida, Freitas, Rita, Ricardo, Sara, Caffrey, Thomas, David, Leonor, Almeida, Raquel, Hollingsworth, Michael Anthony, Santos-Silva, Filipe
Veröffentlicht 2016Text -
9
Development of a MUC16-Targeted Near-Infrared Fluorescent Antibody Conjugate for Intraoperative Imaging of Pancreatic Cancer von Olson, Madeline T., Wojtynek, Nicholas E., Talmon, Geoffrey A., Caffrey, Thomas C., Radhakrishnan, Prakash, Ly, Quan P., Hollingsworth, Michael A., Mohs, Aaron M.
Veröffentlicht 2020Text -
10
Mechanism regulating reactive oxygen species in tumor induced myeloid-derived suppressor cells: MDSC and ROS in cancer von Corzo, Cesar A., Cotter, Matthew J., Cheng, Pingyan, Cheng, Fendong, Kusmartsev, Sergei, Sotomayor, Eduardo, Padhya, Tapan, McCaffrey, Thomas V., McCaffrey, Judith C., Gabrilovich, Dmitry I.
Veröffentlicht 2009Text -
11
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer von Soni, Kruti S., Thomas, Divya, Caffrey, Thomas, Mehla, Kamiya, Lei, Fan, O’Connell, Kelly A., Sagar, Satish, Lele, Subodh M., Hollingsworth, Michael A., Radhakrishnan, Prakash, Bronich, Tatiana K.
Veröffentlicht 2019Text -
12
MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans von Sagar, Satish, Leiphrakpam, Pramila D., Thomas, Divya, McAndrews, Kyle L., Caffrey, Thomas C., Swanson, Benjamin J., Clausen, Henrik, Wandall, Hans H., Hollingsworth, Michael A., Radhakrishnan, Prakash
Veröffentlicht 2021Text -
13
Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors von Swami, Priyanka, O’Connell, Kelly A., Thiyagarajan, Swetha, Crawford, Ayrianne, Patil, Prathamesh, Radhakrishnan, Prakash, Shin, Simon, Caffrey, Thomas C., Grunkemeyer, James, Neville, Tammi, Vetter, Stefan W., Hollingsworth, Michael A., Leclerc, Estelle
Veröffentlicht 2021Text -
14
Cyclin Dependent Kinase 5 is amplified and over-expressed in pancreatic cancer and activated by mutant K-Ras von Eggers, John P., Grandgenett, Paul M., Collisson, Eric C., Lewallen, Michelle E., Tremayne, Jarrod, Singh, Pankaj K., Swanson, Benjamin J., Andersen, Judy M., Caffrey, Thomas C., High, Robin R., Ouellette, Michel, Hollingsworth, Michael A.
Veröffentlicht 2011Text -
15
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment von Corzo, Cesar A., Condamine, Thomas, Lu, Lily, Cotter, Matthew J., Youn, Je-In, Cheng, Pingyan, Cho, Hyun-Il, Celis, Esteban, Quiceno, David G., Padhya, Tapan, McCaffrey, Thomas V., McCaffrey, Judith C., Gabrilovich, Dmitry I.
Veröffentlicht 2010Text -
16
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors von Mehla, Kamiya, Tremayne, Jarrod, Grunkemeyer, James A., O’Connell, Kelly A., Steele, Maria M., Caffrey, Thomas C., Zhu, Xinyi, Yu, Fang, Singh, Pankaj K., Schultes, Birgit C., Madiyalakan, Ragupathy, Nicodemus, Christopher F., Hollingsworth, Michael A.
Veröffentlicht 2017Text -
17
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer von Chaika, Nina V., Gebregiworgis, Teklab, Lewallen, Michelle E., Purohit, Vinee, Radhakrishnan, Prakash, Liu, Xiang, Zhang, Bo, Mehla, Kamiya, Brown, Roger B., Caffrey, Thomas, Yu, Fang, Johnson, Keith R., Powers, Robert, Hollingsworth, Michael A., Singh, Pankaj K.
Veröffentlicht 2012Text -
18
Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia von Shakri, Ahmad Rushdi, Zhong, Timothy James, Ma, Wanchao, Coker, Courtney, Kim, Sean, Calluori, Stephanie, Scholze, Hanna, Szabolcs, Matthias, Caffrey, Thomas, Grandgenett, Paul M., Hollingsworth, Michael A., Tanji, Kurenai, Kluger, Michael D., Miller, George, Biswas, Anup Kumar, Acharyya, Swarnali
Veröffentlicht 2019Text -
19
Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling von Xu, Pauline C., You, Mikyoung, Yu, Seok-Yeong, Luan, Yi, Eldani, Maya, Caffrey, Thomas C., Grandgenett, Paul M., O’Connell, Kelly A., Shukla, Surendra K., Kattamuri, Chandramohan, Hollingsworth, Michael A., Singh, Pankaj K., Thompson, Thomas B., Chung, Soonkyu, Kim, So-Youn
Veröffentlicht 2022Text -
20
EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia vs. benign lesions von Schussel, Juliana, Zhou, Xian Chong, Zhang, Zhe, Pattani, Kavita, Bermudez, Francisco, Jean-Charles, Germain, McCaffrey, Thomas, Padhya, Tapan, Phelan, Joan, Spivakovsky, Silvia, Brait, Mariana, Li, Ryan, Bowne, Helen Yoo, Goldberg, Judith D., Rolnitzky, Linda, Robbins, Miriam, Kerr, A. Ross, Sirois, David, Califano, Joseph A.
Veröffentlicht 2013Text